Clinical Trials
2 trialsNCT05896059 2023-06-09
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04933175 2021-06-21
Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer
Fujian Provincial Hospital
Phase 2 Unknown